BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry’s Largest NGS-Based Proteomics Panel

  May 19, 2025

   · 

  2 min read
• Press Releases

  Prime Medicine Announces Breakthrough Clinical Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease

  May 19, 2025

   · 

  10 min read
• Press Releases

  Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer

  May 19, 2025

   · 

  3 min read
• Press Releases

  GT Biopharma Advances GTB-3650 Phase 1 Trial to Cohort 2 Following Successful Initial Human Dosing and Evidence of Early Immune Activation Signals

  May 19, 2025

   · 

  3 min read
• Press Releases

  Zealand Pharma continues to strengthen strategic leadership of innovation in obesity and related conditions with appointment of Steven Johnson as Chief Development Officer

  May 19, 2025

   · 

  6 min read
• Press Releases

  Shanton to Present Topline Data from Phase 2b Study with SAP-001 in Refractory Gout Patients at EULAR 2025 Congress

  May 19, 2025

   · 

  2 min read
• Press Releases

  Albertsons® Companies Pharmacies Welcomes Rite Aid Customers and Employees

  May 19, 2025

   · 

  4 min read
• Press Releases

  Sunflower Therapeutics Announces the First System Delivery and Installation of the Daisy Petal™ Perfusion Bioreactor System to BioBuilder

  May 19, 2025

   · 

  4 min read
• Press Releases

  DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 (Rinvecalinase Alfa) for the Treatment of Preeclampsia

  May 19, 2025

   · 

  6 min read
• Press Releases

  FDA Grants Interchangeable Designation to Fresenius Kabi’s biosimilar Otulfi® (ustekinumab-aauz)

  May 19, 2025

   · 

  12 min read